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Abstract  
A 73-year-old male patient was admitted with symptoms of decompensated cardiac and pulmonary insufficiency 
with long-lasting history. A tumor-like formation was observed within the clinical examination, covering the whole 
skin of the nose, paranasal region of the left part of the face, as well as the upper and lower left eyelids. The 
lesion was with yellow to brownish surface and dark-reddish to violet discolored peripheral area, composed of 
nodular formations, smooth central surface and firm texture on palpation. The histopathological examination 
verified the diagnosis of hemangioma, which had been congenital, regarding the patient’s history, treated 
surgically about 50 years ago, with signs of recurrence. The presented patient had been treated surgically at the 
age of 20, without medical evidence of the type of the performed excision. The recurrence occurs almost 50 years 
later, at the age of 78. To the best of our knowledge, this is the first reported recurrence of infantile hemangioma, 
treated surgically almost 50 years ago. 
 
 
 
 
 
 
 
 
A 73-year-old male patient was admitted with 
symptoms of decompensated cardiac and pulmonary 
insufficiency with long-lasting history. A tumor-like 
formation was observed within the clinical 
examination, covering the whole skin of the nose, 
paranasal region of the left part of the face, as well as 
the upper and lower left eyelids. The lesion was with 
yellow to brownish surface and dark-reddish to violet 
discolored peripheral area, composed of nodular 
formations, smooth central surface and firm texture on 
palpation (Fig.1). According to patient’s history, he 
underwent a surgical removal of congenital lesion, at 
age of 20. Recently, the formation began to increased 
its size peripherally, becoming more firm in the central 
area. No subjective complaints were reported. The 
histopathological examination verified the diagnosis of 
hemangioma, which had been congenital, regarding 
the patient’s history, treated surgically about 50 years 
ago, with signs of recurrence.  
Surgical excision is nowadays not 
recommended as a first-line therapy in infantile 
hemangiomas, because of the well-established 
tendency of spontaneous regression in one hand, the 
risk of recurrences, and the proven effectiveness of 
numerous other non-surgical regiments in other [1]. 
Although systemic corticosteroids have been 
the first line of treatment for many years, it has been 
recently established that, non-selective beta-blockers, 
such as oral propranalol and topical timolol, are more 
promising and safer therapeutic approaches. 
Furthermore, interferon α and vincristine are suitable 
for life-threatening haemangiomas that are 
unresponsive to conventional therapy [2]. The 
recurrence rate of surgically treated infantile 
hemangiomas accounts approximately 22%, as it 
depends on the patients’ age at the time of the 
surgery and the type of the performed resection 
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(intralesional, marginal, wide and radical resection) 
[1].  
 
Figure 1: Clinical manifestation of tumor-like lesion, located 
predominantly on the left nasal and paranasal region, composed of 
nodular formations, smooth central surface and firm texture on 
palpation 
The presented patient had been treated 
surgically at the age of 20, without medical evidence 
of the type of the performed excision. The recurrence 
occurs almost 50 years later, at the age of 78. To the 
best of our knowledge, this is the first reported 
recurrence of infantile hemangioma, treated surgically 
almost 50 years ago.  
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